Excessive inflammation contributes to a variety of diseases, including cancer. The class of molecules known as resolvins appears to modify disease progression by decreasing inflammation, offering a potential therapeutic option, according to a recent review article published in the World Journal of Clinical Cases and co-authored by Kazuaki Takabe, MD, PhD, FACS, Clinical Chief of Breast Surgery at Roswell Park Cancer Institute.

Unlocking the power of patient data and connecting health care information to improve patient care are two topics that will be presented by information technology experts from Roswell Park Cancer Institute at the annual Allscripts Client Experience conference, August 9–11 in Las Vegas, Nev.

The future is now for 54 students who attend 30 different schools in the Buffalo, N.Y., and Detroit, Mich., areas. These promising young people competed in the 3rd annual Junior Robotic Surgeon Challenge, hosted by Roswell Park Cancer Institute. The program trains high school students in the basics of robot-assisted surgery using the same curriculum used to train surgeons.

New insights on age-related diseases may hold the key to both delaying aging and, in the process, reducing the occurrence of diseases including cancer.